Sales of an over-the-counter nasal spray that powder-coats the nasal membranes, making it difficult for airborne viruses to enter the body, has surged by a whopping 688% in the UK amid fears of the dreaded coronavirus (2019-nCoV).
It’s backed by over 20 clinical trials, which found the nasal spray to reduce upper respiratory tract infections by 90%.
UK Consumers are taking every precaution to protect themselves against contracting 2019-nCoV, which explains the sudden surge in sales of the nasal spray, which is branded as Nexa Shield ™ in South Africa.
Refer to media statement below which also dispels myths around the Coronavirus and provides consumers with advice on how to reduce their risk of infection.
Should you want to interview Nicole Jennings, spokesperson for Pharma Dynamics (leading colds and flu medicine provider) re the topic, please contact me on my cellphone: 082 410 8960 or send me an email to make the necessary arrangements.